Exosome Diagnostics
Meagan Plotner is a skilled Quality Technologist at Exosome Diagnostics, where responsibilities include overseeing reagent quality control and conducting gene expression assays. Previous experience as a Medical Technologist at Atrius Health involved clinical analysis of blood and urine, quality control oversight, and regulatory compliance. At Anna Jaques Hospital, expertise was demonstrated in high-throughput testing and response to critical situations. Initial experience at Burlington Labs involved urine toxicology screening and laboratory maintenance. Academic credentials include a Bachelor of Science in Biology and Chemistry from Salem State University and an Associate of Science in Clinical Laboratory Science from Northern Essex Community College.
This person is not in any offices
Exosome Diagnostics
Exosome Diagnostics is developing biofluid-based molecular diagnostic tests for use in personalized medicine. Exosomes and other microvesicles are shed into all biofluids, including blood, urine and cerebrospinal fluid, forming a highly enriched source of intact, disease-specific nucleic acids. The Company's proprietary exosome technologymakes use of this natural enrichment to achieve high sensitivity and specificity for rare gene transcripts and the expression of genes responsible for cancers and other diseases.